Skip to main content
Premium Trial:

Request an Annual Quote

GeneTrace Allies With Monsanto, Names CEO

Premium

MENLO PARK, Calif.--GeneTrace announced it will collaborate with Monsanto on plant and animal genomics research. Monsanto will make a $17.2 million investment in GeneTrace, a genetic information provider based here. Monsanto will get exclusive options to license all aspects of GeneTrace's genomics technologies for plant and animal agriculture worldwide, research and development funding, equipment purchases, supply agreements, and an equity investment. As part of the initial agreement, Monsanto has exercised an option to license GeneTrace's genotyping methods and intends to use the technology for many crops, including corn and soybeans.

GeneTrace also announced that it has appointed George LaMotte to the position of CEO. LaMotte, who holds a PhD in molecular immunology from Cornell and was a fellow in molecular immunology at Scripps Clinic and Research Foundation, most recently served with the healthcare business consultants Owen & Associates.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.